| 翻訳と辞書 |
Myrexis
Myrexis is a biopharmaceutical company based in Salt Lake City, Utah, USA. It focuses on drug development in several areas of medicine, in particular cancer therapy. It was founded in 1999 as a spin-off from Myriad Genetics〔Staff (2 July 2009) ("Myriad Pharmaceuticals, Inc. Established As An Independent Pharmaceutical Development Company" ) ''Pharmaceutical Online'', 2 July 2009. Retrieved 26 July 2014〕 and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from May 2012 until his death in August 2012.〔(【引用サイトリンク】title=Myrexis Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate ) 〕
In November 2012, the board of Myrexis announced that it planned to put the company into liquidation subject to shareholder approval.〔Tadena, Nathalie, ("Myrexis Board Approves Plan to Liquidate Assets, Dissolve Company" ), ''The Wall Street Journal'', 9 November 2012. Retrieved 20 January 2013 〕 In January 2013, the board reversed its decision, cancelled the liquidation, declared a special cash distribution to shareholders and appointed Jonathan M. Couchman (chairman of Xselos Holdings) as president and chief executive officer. The remaining members of the board then resigned.〔Myrexis Inc press release:("Myrexis, Inc. Announces the Cancellation of Its Upcoming Shareholder Meeting" ), carried by ''Bloomberg'', 23 January 2013. Retrieved 26 July 2014〕
==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Myrexis」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|